Amy Simon Beam Therapeutics Inc. (BEAM) insider trading activity
Amy Simon is Chief Medical Officer of Beam Therapeutics Inc.. Currently has a direct ownership of 64,864 shares of BEAM, which is worth approximately $1.3 Million. The most recent transaction as insider was on Jul 03, 2025, when has been sold 876 shares (Common Stock) at a price of $20.12 per share, resulting in proceeds of $17,625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
64.9K
1.34%
3M change
5.73%
12M change
Total Value Held
$1.3 Million
Amy Simon Transaction History
AS
Amy Simon
Chief Medical Officer
Cambridge, MA